Who is sponsoring NCT00204958?

NCT00204958 is sponsored by University of Wisconsin, Madison.

What drugs are being tested in NCT00204958?

Interventions in NCT00204958: nutritional supplement, glutamine popsicle.

What condition does NCT00204958 study?

NCT00204958 studies Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantion.

Is NCT00204958 still recruiting?

NCT00204958 is currently completed. Last updated 29 September 2015.

Last reviewed 2015-09-29 · How we verify

NCT00204958

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Glutamine Popsicles in Adult/Pediatric Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients

Completed Phase 4 Last updated 29 September 2015

What this trial tests

Phase 4 trial testing nutritional supplement in Bone Marrow Transplantation in 50 participants. Completed in 1 May 2007.

Timeline

1 February 2004

Primary endpoint
1 May 2007

1 May 2007

Quick facts

Lead sponsor	University of Wisconsin, Madison
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	double
Primary purpose	prevention
Enrollment	50
Start date	1 February 2004
Primary completion	1 May 2007
Estimated completion	1 May 2007
Sites	1 location across United States

Drugs / interventions tested

nutritional supplement — full drug profile →
glutamine popsicle — full drug profile →

Conditions studied

Bone Marrow Transplantation — all drugs for Bone Marrow Transplantation →
Hematopoietic Stem Cell Transplantion — all drugs for Hematopoietic Stem Cell Transplantion →

Sponsor

University of Wisconsin, Madison

Who can join

Adults 4 to 75, any sex, with Bone Marrow Transplantation or Hematopoietic Stem Cell Transplantion. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

grade of mucositis

Sponsor's own description

Nutrition is an important part of the recovery process after having a head injury so that subjects can gain strength and fight off infection. Liquid nutrition formulas are often given to patients through a tube that has been placed into the intestines for feeding when they are unable to eat on their own. Some reports suggest that nutrition with extra amounts of the amino acid called glutamine may decrease infections and hospital stay in severely injured patients. The purpose of this study is to evaluate if giving extra amounts of an amino acid called glutamine with liquid nutrition formulas will decrease the risk of infection and length of stay in the intensive care unit after having a head injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bone Marrow Transplantation

Currently open trials in the same condition.

NCT07205523 — High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) · recruiting
NCT04645199 — National Longitudinal Cohort of Hematological Diseases · recruiting

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
NCT07470723 — The ORIGIN-FH Study · NA · recruiting
NCT06975657 — Well-being Skills for Reentry · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00204958 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
Last refreshed: 29 September 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00204958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing